Your browser doesn't support javascript.
loading
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain.
Chen, Zhendong; Taubert, Max; Chen, Chunli; Dokos, Charalambos; Fuhr, Uwe; Weig, Thomas; Zoller, Michael; Heck, Suzette; Dimitriadis, Konstantinos; Terpolilli, Nicole; Kinast, Christina; Scharf, Christina; Lier, Constantin; Dorn, Christoph; Liebchen, Uwe.
Afiliação
  • Chen Z; Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Taubert M; Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Chen C; Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Dokos C; Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, College of Veterinary Medicine, Northeast Agricultural University, Harbin, People's Republic of China.
  • Fuhr U; Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Weig T; Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Zoller M; Department of Anesthesiology, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
  • Heck S; Department of Anesthesiology, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
  • Dimitriadis K; Department of Neurology, University Hospital, Ludwig Maximilian University, Munich, Germany.
  • Terpolilli N; Department of Neurology, University Hospital, Ludwig Maximilian University, Munich, Germany.
  • Kinast C; Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig Maximilians University, Munich, Germany.
  • Scharf C; Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig Maximilians University, Munich, Germany.
  • Lier C; Department of Neurosurgery, Munich University Hospital, Munich, Germany.
  • Dorn C; Department of Anesthesiology, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
  • Liebchen U; Department of Anesthesiology, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
Antimicrob Agents Chemother ; 67(6): e0024123, 2023 06 15.
Article em En | MEDLINE | ID: mdl-37162349
ABSTRACT
Vancomycin is a commonly used antibacterial agent in patients with primary central nervous system (CNS) infection. This study aims to examine predictors of vancomycin penetration into cerebrospinal fluid (CSF) in patients with external ventricular drainage and the feasibility of CSF sampling from the distal drainage port for therapeutic drug monitoring. Fourteen adult patients (9 with primary CNS infection) were treated with vancomycin intravenously. The vancomycin concentrations in blood and CSF (from proximal [CSF_P] and distal [CSF_D] drainage ports) were evaluated by population pharmacokinetics. Model-based simulations were conducted to compare various infusion modes. A three-compartment model with first-order elimination best described the vancomycin data. Estimated parameters included clearance (CL, 4.53 L/h), central compartment volume (Vc, 24.0 L), apparent CSF compartment volume (VCSF, 0.445 L), and clearance between central and CSF compartments (QCSF, 0.00322 L/h and 0.00135 L/h for patients with and without primary CNS infection, respectively). Creatinine clearance was a significant covariate on vancomycin CL. CSF protein was the primary covariate to explain the variability of QCSF. There was no detectable difference between the data for sampling from the proximal and the distal port. Intermittent infusion and continuous infusion with a loading dose reached the CSF target concentration faster than continuous infusion only. All infusion schedules reached similar CSF trough concentrations. Beyond adjusting doses according to renal function, starting treatment with a loading dose in patients with primary CSF infection is recommended. Occasionally, very high and possibly toxic doses would be required to achieve adequate CSF concentrations, which calls for more investigation of direct intraventricular administration of vancomycin. (This study has been registered at ClinicalTrials.gov under registration no. NCT04426383).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vancomicina / Infecções do Sistema Nervoso Central Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vancomicina / Infecções do Sistema Nervoso Central Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha